✦ LIBER ✦

High-dose aminothiadiazole in advanced colorectal cancer

✍ Scribed by Gershon Y. Locker; Lary Kilton; Janardan D. Khandekar; Thomas E. Lad; Richard H. Knop; Kathy Albain; Richard Blough; Suzanne French; Al. B. Benson

Publisher: Springer US
Year: 1994
Tongue: English
Weight: 173 KB
Volume: 12
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00873044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of high-dose intravenou

A phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer

✍ Robert M. Silgals; James D. Ahlgren; John R. Neefe; John Rothman; Seth Rudnick; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

Doxifluridine in advanced colorectal can

Doxifluridine in advanced colorectal cancer

✍ Federico Calabresi; Marina Repetto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

High-dose versus low-dose CMFP regimen i

High-dose versus low-dose CMFP regimen in advanced breast cancer

✍ Anand Kumar; N. N. Khanna; C. C. Pant; S. Khanna 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Fifty cases of advanced breast cancer (stages III and IV) were treated by combination chemotherapy. The study compares the two different dose schedules and toxicities of a combination of cyclophosphamide, methotrexate, 5-flurouracil, and prednisone. Results are better with high-dose regimen, though

High-dose cisplatin in advanced head and

High-dose cisplatin in advanced head and neck cancer

✍ Arlene A. Forastiere; Bonnie J. Takasugi; Shan R. Baker; Gregory T. Wolf; Vickie 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 452 KB

In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with

High-dose ifosfamide and mesna in advanc

High-dose ifosfamide and mesna in advanced breast cancer

✍ F. Sanchiz; A. Milla 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 182 KB

Dose of rofecoxib in colorectal cancer

✍ José Francisco Noguera Aguilar; Isabel Amengual Antich; Juan José Pujol Tugores 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 35 KB

## Dear Sir, We have read with interest the article of Becerra et al. 1 about the increased toxicity and lack of efficacy of rofecoxib in combination with chemotherapy in the treatment of metastatic colorectal cancer. The dose of rofecoxib employed in their clinical study was 50 mg/day, with a re